Search for European Projects

Over 40 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Advanced Immunization Technologies (ADITEC)

Start date: Oct 1, 2011, End date: Sep 30, 2017,

Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious diseases we need to fully exploit the potential of the human immune system. Progress in science and technology makes it possible to achieve what was previously deemed impossible. The scope of this project is to produce knowledge necessary to develop novel and ...
Read Project

 53

 FINISHED 

European Multicentre Tics in Children Studies (EMTICS)

Start date: Dec 1, 2011, End date: May 31, 2017,

This project will undertake pre-clinical and cohort studies that address susceptibility factors for paediatric and adolescent tic disorders, with a particular focus on comorbid obsessive-compulsive symptomatology, from clinical, epidemiological, genetic, microbiological and immunological angles. EMTICS aims to elucidate the complex aetiology of the onset and clinical course of chronic tic disorder ...
Read Project

 33

 FINISHED 

Open Project for the European Radiation Research Area (OPERRA)

Start date: Jun 1, 2013, End date: May 31, 2017,

"Within the OPERRA project, it is proposed that the MELODI Association, as a well-advanced network, takes the lead in establishing the necessary structures able to manage the long-term European research programmes in radiation protection, also taking advantage of the valuable experience gathered through the DoReMi network of excellence. Whilst in fields adjacent to low-dose risk research (radioeco ...
Read Project

 71

 FINISHED 

Risk, Stem Cells and Tissue Kinetics – Ionising Radiation (RISK - IR)

Start date: Nov 1, 2012, End date: Apr 30, 2017,

The magnitude of cancer risk in humans exposed to low radiation doses (
Read Project

 16

 FINISHED 
Antibiotics are a mainstay of public health, but their use has increased exponentially leading to the emergence of antibiotic resistance. The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) project combines 5 international clinical studies, all supported by highly innovative microbiology, mathematical modelling and data-management, to determine - in the most rele ...
Read Project

 27

 FINISHED 
The innovative and economic potential of Manufactured Nano Materials (MNMs) is threatened by a limited understanding of the related EHS issues. While toxicity data is continuously becoming available, the relevance to regulators is often unclear or unproven. The shrinking time to market of new MNM drives the need for urgent action by regulators. NANoREG is the first FP7 project to deliver the answe ...
Read Project

 73

 FINISHED 

Biomarkers For Enhanced Vaccine Safety (BIOVACSAFE)

Start date: Mar 1, 2012, End date: Dec 31, 2016,

BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised into focused Activity Cores to generate knowledge and tools to benchmark licensed vaccine reactogenicity, and create practical and generalizable guidelines and techniques to enhance immunosafety of novel vaccines from pre-development to post-marketing surveil ...
Read Project

 24

 FINISHED 
The rapid worldwide increase in mobile phone use in adolescents and, more recently, children has generated considerable interest in the possible health effects of exposure to radio frequency (RF) fields. The current project aims to assess the potential carcinogenic effects of childhood and adolescent exposure to RF and ELF from mobile telephones on tumours of the central nervous system. The study ...
Read Project

 18

 FINISHED 
This proposal aims to close gaps that have been identified in nuclear and radiological preparedness following the first evaluation of the Fukushima disaster. It addresses the call Fission-2010-3.3.1: Update of emergency management and rehabilitation strategies and expertise in Europe. The consortium intends to review existing operational procedures in dealing with long lasting releases, address th ...
Read Project

 50

 FINISHED 

Realizing the European Network in Biodosimetry (RENEB)

Start date: Jan 1, 2012, End date: Dec 31, 2015,

Creating a sustainable network in biological dosimetry that involves a large number of experienced laboratories throughout the EU will significantly improve the accident and emergency response capabilities in case of a large-scale radiological emergency. A well organised cooperated action involving EU laboratories will offer the only chance for a fast and trustworthy dose assessment urgently neede ...
Read Project

 28

 FINISHED 
... ound database and repository of selected test compounds, and a reference resource for cells, cell lines and tissues of relevance for in vitro systemic toxicity research carried out across the FP7 HEALTH.2010.4.2.9 Alternative Testing Strategies SEURAT program. The project develops infrastructure and service functions to create a sustainable predictive toxicology support resource going beyond the l ...
Read Project

 10

 FINISHED 
In the development of products for use by humans it is vital to identify compounds with toxic properties at an early stage of their development, to avoid spending time and resource on unsuitable and potentially unsafe candidate products. Human pluripotent stem cell lines offer a unique opportunity to develop a wide variety of human cell-based test systems because they may be expanded indefinitely ...
Read Project

 16

 FINISHED 

Low Dose Research towards Multidisciplinary Integration (DOREMI)

Start date: Jan 1, 2010, End date: Dec 31, 2015,

The aim of DoReMi is to promote the sustainable integration of low dose risk research in Europe in order to aid the effective resolution of the key policy questions identified by the High Level Expert Group (HLEG) on Low Dose Risk Research (www.hleg.de). DoReMi provides an operational tool for the development of the proposed MELODI platform (Multidisciplinary European Low Dose Risk Re-search Initi ...
Read Project

 39

 FINISHED 
Biomedical research depends on the availability of living non-human primates and biological material with primate origin. The need for animal research using non-human primates is therefore recognised by all governments that support internationally competitive biomedical research aimed at addressing the world’s most pressing medical challenges. While essential for biomedical research owing to their ...
Read Project

 13

 FINISHED 
The NANOPUR-project aims at leveraging on promising bottom-up technologies to develop intensified water treatment concepts based on nano-structured and nano-functionalized membranes as well as nanofilm deposition for micropollutants and virus removal.Major research needs targeted include the preparation of membranes with selective properties at the nanoscale able to maintain high permeability with ...
Read Project

 15

 FINISHED 
... n apoptosis, cell proliferation, differentiation and genomic instability will be explored with 2D cell cultures and 3D tissue models. This includes research on stem cells, which will be isolated from healthy human breast tissue. The results of the radiobiological studies will be integrated in the development of models of carcinogenesis for evaluation of major epidemiological cohorts: Atomic Bomb S ...
Read Project

 23

 FINISHED 
Epidemiological evidence has established a link between cardiovascular disease and exposure of the heart and major vessels to doses above 500mGy. At lower doses the evidence for a detrimental effect is inconclusive. In part, this is due to the lack of appropriate epidemiological studies, coupled with lack of knowledge of the processes involved that is needed for construction of mathematical models ...
Read Project

 15

 FINISHED 

"Neutralizing antibodies against botulinum toxins A,B,E" (ANTIBOTABE)

Start date: Sep 1, 2010, End date: Feb 28, 2015,

"Botulinum neurotoxins (BoNTs), the most toxic substances known, are susceptible for use as bioweapons (listed as class A agents by CDC). Currently licensed animal derived antibodies or F(ab’)2 preparations, are at a high risk of inducing adverse effects and their privately-owned stockpiles are limited. In this project, we will target the most lethal types of BoNTs: A (subtypes A1 and A2), B (B1 a ...
Read Project

 11

 FINISHED 

Epidemiological Studies of Exposed Southern Urals Populations (SOLO)

Start date: Mar 1, 2010, End date: Feb 28, 2015,

This project aims to improve estimates of the risks of long-term health effects associated with protracted external and internal radiation exposures, through further studies of exposed populations in the Southern Urals (Russian Federation). Specific objectives of the project are as follows: 1. To develop improved modules for estimating external doses to exposed cohorts in the Southern Urals. It is ...
Read Project

 13

 FINISHED 

European Virus Archive (EVA)

Start date: Jan 1, 2009, End date: Dec 31, 2014,

"During the past 70 years or more, thousands of viruses have been isolated and partly characterised by experts working in different countries worldwide. These viruses potentially provide a unique and extremely valuable medical and educational resource for research and development to understand the basis of virus diseases, and to develop modern state of the art strategies for disease control. Howev ...
Read Project

 11

 FINISHED 
The objective of PRACTICE project is to improve the preparedness and resilience of the EU member states and associated countries to an attack from a terrorist group using non conventional weapons such as CBRN (Chemical, Biological, Radiological and/or Nuclear agents) materials. The existing situation is characterized by a fragmented structure as regards technology, procedures, methods and organiza ...
Read Project

 28

 FINISHED 

European Research Infrastructure on Highly Pathogenic Agents (ERINHA)

Start date: Nov 1, 2010, End date: Aug 31, 2014,

In the context of the emerging and re-emerging infectious diseases involving highly pathogenic microorganisms, European countries have to be well-prepared to face such threats. However, the Biosafety Level 4 (BSL4) capacity in Europe is not sufficient enough to cover the efficient development of diagnosis, prophylactic and therapeutics means against these pathogens. Moreover, there is no global co ...
Read Project

 27

 FINISHED 

Standardisation of laboratory analytical methods (SLAM)

Start date: Apr 1, 2012, End date: Mar 31, 2014,

SLAM is a project proposal for a supporting and coordinating activity with the objective of reviewing the needs for standardisation of CBRN analysis and suggesting a road map for its implementation. All partners to the SLAM consortium are significant players in on-going dialogues on CBRN analytical requirements and procedures on the European scene. The composition of this consortium is well-balanc ...
Read Project

 10

 FINISHED 
"With 14.4 million prevalent cases and 1.7 million deaths tuberculosis (TB) remains one of the most serious infectious diseases to date. An estimated 2 billion people are believed to be infected with Mycobacterium tuberculosis and at risk of developing disease. Multi- and extensively drug resistant strains are increasingly appearing in many parts of the world, including Europe. While with current ...
Read Project

 39

 FINISHED 
This project aims on the one hand to keep the momentum gained through the European Project EURANOS in establishing a platform where the operational and research community can meet and discuss with all the relevant stakeholders the topics related to emergency response and recovery preparedness and on the other hand to tackle urgent research topics in the area of nuclear emergency response and recov ...
Read Project

 22

 FINISHED 

European Clearing House for Open Robotics Development (ECHORD)

Start date: Jan 1, 2009, End date: Dec 31, 2013,

Description Strengthening the knowledge transfer between scientific research and industry in robotics and stimulating their cooperation In Europe the robotics industry is strong, but still fragmented and dispersed. The objective of ECHORD is to provide new opportunities for coordinated and target- ...
Read Project

 105

 FINISHED 

Embryonic Stem cell-based Novel Alternative Testing Strategies (ESNATS)

Start date: Apr 1, 2008, End date: Sep 30, 2013,

"ESNATS aims at developing a novel toxicity test platform based on embryonic stem cells (ESC), especially human ESC (hESC), to accelerate drug development, reduce R&D costs and propose a powerful alternative to animal tests (3 Rs). ESNATS will address current drug-testing shortcomings: - testing takes place late in the development cycle - animal test systems bear the risk of non-prediction due to ...
Read Project

 34

 FINISHED 

European Network of Vaccine Development and Research (TRANSVAC)

Start date: Oct 1, 2009, End date: Sep 30, 2013,

"The TRANSVAC infrastructure will accelerate the pharmaceutical and clinical development of promising vaccine candidates by bringing the gap between academic research and clinical trials through carefully managing the advancement of promising vaccine candidates from preclinical animal models to early proof-of-principle studies in humans. Although expertise already exists within Europe spanning dif ...
Read Project

 18

 FINISHED 
"In the event of a large scale radiological emergency biological dosimetry is an essential tool that can provide timely assessment of radiation exposure to the general population and enable the identification of those exposed people, who should receive medical treatment. A number of biodosimetric tools are potentially available, but they must be adapted and tested for a large-scale emergency scena ...
Read Project

 17

 FINISHED 
We will determine the adverse and beneficial health effects of personal UVR exposure and their relationships with climatic and environmental factors that modify the solar UVR spectrum. Date and time stamped personal electronic wristwatch dosimeters will be worn to measure individual UVR exposure over extended periods. Satellite and ground station data will be gathered to establish terrestrial UVR ...
Read Project

 10

 FINISHED 
"As is the case with all nuclear expertise, there is a trend of a decreasing number of experts in radiation protection due to various reasons. On the other hand, current activities in the nuclear domain are expanding: the nuclear industry faces a so-called "renaissance", high-tech medical examinations based on ionising radiation are increasingly used, and research and non-nuclear industry also mak ...
Read Project

 13

 FINISHED 

European coordination action on human biomonitoring (COPHES)

Start date: Dec 1, 2009, End date: Nov 30, 2012,

... d including scientists, government institutions and authorities, NGOs and industry. The main goal is to develop a coherent approach to HBM in Europe as requested by ACTION 3 of the EU Environment and Health Action Plan through coordination of ongoing and planned HBM activities. The project will exploit existing and planned HBM projects and programmes of work and capabilities in Europe. The consort ...
Read Project

 40

 FINISHED 
Outstanding progress has been made in recent years in developing novel structures and applications for direct fabrication of 3D nanosurfaces. However, exploitation is limited by lack of suitable manufacturing technologies. In this project we will develop innovative in-line high throughput technologies based on atmospheric pressure surface and plasma technologies. The two identified approaches to d ...
Read Project

 22

 FINISHED 

Translational Research on Combating Antimicrobial Resistance (TROCAR)

Start date: Jan 1, 2009, End date: Jun 30, 2012,

"The health care systems of most European countries are based on a continuum from acute care hospitals, though other health care facilities to the community. Such a framework provides the perfect opportunity for the wide-spread dissemination of high-risk resistant clones or genetic resistant elements. The driving concept of TROCAR is to investigate the fundamentals of the epidemiology of new high ...
Read Project

 14

 FINISHED 
"Enteric infections remain a major cause of morbidity and mortality globally, accounting for an estimated 2 millions deaths each year. Effective preventive and therapeutic interventions are not yet available for many etiological agents of diarrheal diseases. Furthermore, even where vaccines are available, the lag time needed to induce an immune response can be critical in epidemic situations. We ...
Read Project

 8

 FINISHED 

Nasal Pandemic Influenza Vaccine (NASPANVAC)

Start date: May 1, 2008, End date: Apr 30, 2012,

"The project is being undertaken in response to the need to develop an effective, user friendly, heat stable vaccine to control the highly pathogenic form of avian influenza virus (H5 and H7 subtypes) which has the potential to cause another global influenza pandemic. The overall objective of this programme is to develop a nasal avian influenza vaccine using ChiSys® (chitosan), which is a chitosan ...
Read Project

 8

 FINISHED 
"A broad-range of candidate malaria vaccines derived from diverse novel technologies have resulted from the multiple approaches being taken by different groups in developing malaria vaccines. The majority of the candidates are recombinant proteins based on complex native antigens found on the surface of the parasite. Vaccine potential of these parasite surface antigens is often supported by epidem ...
Read Project

 14

 FINISHED 
"The European Space Agency’s project MATROSHKA (MTR), dedicated to determine the radiation load on astronauts in- and outside the International Space Station (ISS), launched in Jan. 2004 and is currently in its experimental phase 3. MTR is an anthropomorphic upper torso phantom containing over 6,000 radiation detectors to determine the depth- and organ dose distribution in the body. It is the larg ...
Read Project

 8

 FINISHED 
"Direct vaccination cannot prevent diseases that affect neonates in the first days of life. Group B Streptococcus (GBS) is the major cause of neonatal septicemia and meningitis affecting up to one in every thousand live births. Over 80% of cases occur in the first 7 days after birth and the remaining 20% of disease occurs between 8-90 days after birth. Studies carried out in the USA indicate that ...
Read Project

 10

 FINISHED 
"RANGER addresses the HEALTH-2007-2.3.3-4: Innovative point-of-care (POC) diagnostic tests for influenza call by providing a innovative solution to the immediate need for a rapid, robust, cost effective & user friendly POC diagnostic for influenza. We will develop the following real-time PCR system: 1) A robust, portable system allowing testing at the POC anywhere in the world 2) Raw sample to ...
Read Project

 9